Minocycline for the treatment of Takayasu arteritis [4]

Annals of Internal Medicine

Volumn 143, Issue 5, 2005, Pages 394-395

  Matsuyama, Akifumi ^a   Sakai, Naohiko ^a   Ishigami, Masato ^a   Hiraoka, Hisatoyo ^a   Yamashita, Shizuya ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GELATINASE A; GELATINASE B; MINOCYCLINE; PREDNISOLONE; STEROID; STROMELYSIN;

AORTA ARCH SYNDROME; CHRONIC DISEASE; CLINICAL ARTICLE; DISEASE ACTIVITY; DRUG EFFICACY; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; LABORATORY TEST; LETTER; PRIORITY JOURNAL; REMISSION; STEROID THERAPY; TREATMENT OUTCOME; VASCULITIS;

EID: 24644456863     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-143-5-200509060-00021     Document Type: Letter

References (5)

1. Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum. 1990;33:1129-34. [PMID: 1975175]
2. Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, et al. Takayasu arteritis. Ann Intern Med. 1994;120:919-29. [PMID: 7909656]
3. Matsuyama A, Sakai N, Ishigami M, Hiraoka H, Kashine S, Hirata A, et al. Matrix metalloproteinases as novel disease markers in Takayasu arteritis. Circulation. 2003;108:1469-73. [PMID: 12952836]
4. Matter H, Schudok M. Recent advances in the design of matrix metalloprotease inhibitors. Curr Opin Drug Discov Devel. 2004;7:513-35. [PMID: 15338961]
5. Cooper SM. Tetracyclines. In: Ruddy S, Harris ED, Sledge CB, eds. Kelley's Textbook of Rheumatology. Philadelphia: WB Saunders; 2001:913-20.